Loading clinical trials...
Loading clinical trials...
Topical Squalamine in the Treatment of Retinal Neovascularization From Proliferative Diabetic Retinopathy
Conditions
Interventions
Squalamine Lactate ophthalmic solution 0.2%
Locations
1
United States
Elman Retina Group, P.A.
Baltimore, Maryland, United States
Start Date
February 1, 2013
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
February 10, 2015
NCT02088151
NCT04650672
NCT02486484
NCT02033018
NCT01102946
Lead Sponsor
Elman Retina Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions